Grantopen🌐 United StatesRFA-DA-27-015

Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: May 21, 2026
Response deadline: Sep 30, 2026, 12:00 AM UTC (81d)
Type: Grant
Category: 93.279
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-DA-27-015

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
United States · Jun 9, 2026
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed)
United States · May 4, 2026
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
United States · Jun 9, 2026
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
United States · Jun 1, 2026
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
United States · Jun 4, 2026
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
United States · Jan 15, 2025

Similar past solicitations

Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025
Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
United States · Aug 23, 2024
Providers Clinical Support System – Substance Use Disorder Treatment (PCSS-SUD Treatment)
United States · May 15, 2026
Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
United States · Sep 9, 2024
Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
United States · Aug 6, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.